SCHEMBL1338159

SCHEMBL1338159

Cn1c(=O)c(-c2ccc(Cl)cc2)cc2c3cc(-c4ccn[nH]4)ccc3n(C)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.45
▸ PTPN11 Q06124 1/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ NOTUM Q6P988 4/20 0.39
▸ BRD4 O60885 2/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ MAP2 P11137 1/20 0.37
▸ BRAF P15056 1/20 0.37
▸ BRD2 P25440 1/20 0.37
▸ BRD3 Q15059 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ ATR Q13535 1/20 0.35
▸ ATRIP Q8WXE1 1/20 0.35
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ HTR6 P50406 1/20 0.33
▸ PSEN1 P49768 1/20 0.33
▸ PSEN2 P49810 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1338074 0.90 L3MBTL1 (0.40) POLBPTPN11L3MBTL1NOTUMBRD4
SCHEMBL1339086 0.89 L3MBTL1 (0.42) POLBL3MBTL1NOTUMBRAFJAK2
SCHEMBL1338537 0.89 L3MBTL1 (0.44) L3MBTL1NOTUMBRAFJAK2ATR
SCHEMBL1338390 0.88 L3MBTL1 (0.43) POLBPTPN11L3MBTL1NOTUMBRD4
SCHEMBL1338123 0.84 L3MBTL1 (0.39) POLBPTPN11L3MBTL1NOTUMPIM1
SCHEMBL1338786 0.82 L3MBTL1 (0.50) L3MBTL1NOTUM
SCHEMBL1339283 0.81 MAPK14 (0.43) BRAFCYP3A4CYP2D6PSEN1PSEN2
SCHEMBL1337392 0.79 HSD17B10 (0.46) L3MBTL1LMNAPSEN1PSEN2APH1B
SCHEMBL4762650 0.78 CYP3A4 (0.34) POLBCYP3A4
SCHEMBL3866299 0.75 HSD17B10 (0.44) POLBL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063061-B2 6-(2-amino-1,3-thiazol-4-yl)-3-(2,4-dichlorophenyl)-1-methyl-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one; affinity for GABAA-receptor-associated omega modulatory sites SANOFI-AVENTIS (FR) 2011-11-22 — — US disclosed
EP-1940840-B1 6-HETEROARYLPYRIDOINDOLONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2010-07-21 — — EP disclosed
Send feedback